Levi & Korsinsky reminds Geron investors of pending class action lawsuit with lead …

Investors in Geron have been alerted to an ongoing class action lawsuit, with a deadline for lead plaintiff submissions set on May 12, 2025. Law firm Levi & Korsinsky has issued a reminder regarding this pending legal action.

The lawsuit concerns allegations that Geron made false and misleading statements to its investors, particularly regarding the efficacy and timeline of its clinical trials. Shareholders who purchased Geron stocks between March 19, 2018, and September 26, 2018, are encouraged to participate in the class action lawsuit.

Geron investors are reminded to consider their legal options before the upcoming deadline. By participating as a lead plaintiff, investors have the opportunity to actively contribute to the case’s development on behalf of the class and potentially receive financial compensation if the lawsuit is successful.

The law firm Levi & Korsinsky urges those who may have been affected by Geron’s alleged misleading statements to take action before the deadline passes. This is a crucial opportunity for investors to seek justice and potentially recover any financial losses incurred as a result of the alleged misconduct.

Investors in Geron should be aware of the pending class action lawsuit and the approaching deadline for lead plaintiff submissions. It is essential to stay informed and consider all available legal avenues to address any potential harm caused by the company’s alleged false statements.

Potential lead plaintiffs are encouraged to consult legal counsel to understand their rights and options in participating in the class action lawsuit against Geron. Time is of the essence, and investors should act promptly to ensure their voices are heard in seeking redress for any losses suffered due to the alleged securities fraud.